{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "OtherID": [], "CitationSubset": ["IM"], "InvestigatorList": [], "SpaceFlightMission": [], "GeneralNote": [], "OtherAbstract": [], "PMID": "27160533", "DateCompleted": {"Year": "2017", "Month": "02", "Day": "06"}, "DateRevised": {"Year": "2022", "Month": "04", "Day": "08"}, "Article": {"ArticleDate": [], "ELocationID": [], "Language": ["eng"], "Journal": {"ISSN": "1875-533X", "JournalIssue": {"Volume": "23", "Issue": "23", "PubDate": {"Year": "2016"}}, "Title": "Current medicinal chemistry", "ISOAbbreviation": "Curr Med Chem"}, "ArticleTitle": "Development of Anticancer Agents from Plant-Derived Sesquiterpene Lactones.", "Pagination": {"StartPage": "2397", "EndPage": "2420", "MedlinePgn": "2397-420"}, "Abstract": {"AbstractText": ["Sesquiterpene lactones are of considerable interest due to their potent bioactivities, including cancer cell cytotoxicity and antineoplastic efficacy in in vivo studies. Among these compounds, artesunate, dimethylaminoparthenolide, and L12ADT peptide prodrug, a derivative of thapsigargin, are being evaluated in the current cancer clinical or preclinical trials. Based on the structures of several antitumor sesquiterpene lactones, a number of analogues showing greater potency have been either isolated as natural products or partially synthesized, and some potential anticancer agents that have emerged from this group of lead compounds have been investigated extensively. The present review focuses on artemisinin, parthenolide, thapsigargin, and their naturally occurring or synthetic analogues showing potential anticancer activity. This provides an overview of the advances in the development of these types of sesquiterpene lactones as potential anticancer agents, including their structural characterization, synthesis and synthetic modification, and antitumor potential, with the mechanism of action and structure-activity relationships also discussed. It is hoped that this will be helpful in stimulating the further interest in developing sesquiterpene lactones and their derivatives as new anticancer agents."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [], "LastName": "Ren", "ForeName": "Yulin", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Yu", "ForeName": "Jianhua", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, Columbus, OH 43210, United States."}], "LastName": "Kinghorn", "ForeName": "A Douglas", "Initials": "AD"}], "GrantList": [{"GrantID": "P01 CA125066", "Acronym": "CA", "Agency": "NCI NIH HHS", "Country": "United States"}, {"GrantID": "R01 CA185301", "Acronym": "CA", "Agency": "NCI NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "United Arab Emirates", "MedlineTA": "Curr Med Chem", "NlmUniqueID": "9440157", "ISSNLinking": "0929-8673"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents, Phytogenic"}, {"RegistryNumber": "0", "NameOfSubstance": "Artemisinins"}, {"RegistryNumber": "0", "NameOfSubstance": "Lactones"}, {"RegistryNumber": "0", "NameOfSubstance": "Sesquiterpenes"}, {"RegistryNumber": "9RMU91N5K2", "NameOfSubstance": "artemisinin"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["chemical synthesis", "pharmacology", "therapeutic use"], "DescriptorName": "Antineoplastic Agents, Phytogenic"}, {"QualifierName": ["drug effects"], "DescriptorName": "Apoptosis"}, {"QualifierName": ["chemistry", "pharmacology", "therapeutic use"], "DescriptorName": "Artemisinins"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["chemistry", "pharmacology", "therapeutic use"], "DescriptorName": "Lactones"}, {"QualifierName": ["drug therapy", "pathology"], "DescriptorName": "Neoplasms"}, {"QualifierName": ["chemistry", "metabolism"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["chemistry"], "DescriptorName": "Sesquiterpenes"}, {"QualifierName": [], "DescriptorName": "Structure-Activity Relationship"}], "CoiStatement": "The authors confirm that this article content has no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Chadwick M, Trewin H, Gawthrop F, Wagstaff C. Sesquiterpenoid lactones: Benefits to plants and people. Int. J. Mol. Sci. 2013;14:12780\u201312805.", "ArticleIdList": ["PMC3709812", "23783276"]}, {"Citation": "Staneva JD, Todorova MN, Evstatieva LN. Sesquiterpene lactones as chemotaxonomic markers in genus. Anthemis. Phytochemistry. 2008;69:607\u2013618.", "ArticleIdList": ["17850834"]}, {"Citation": "Zidorn C. Sesquiterpene lactones and their precursors as chemosystematic markers in the tribe Cichorieae of the Asteraceae. Phytochemistry. 2008;69:2270\u20132296.", "ArticleIdList": ["18715600"]}, {"Citation": "Rodriguez E, Towers GHN, Mitchell JC. Biological activities of sesquiterpene lactones. Phytochemistry. 1976;15:1573\u20131580."}, {"Citation": "Repetto MG, Boveris A. Bioactivity of sesquiterpenes: compounds that protect from alcohol-induced gastric mucosal lesions and oxidative damage. Mini-Rev. Med. Chem. 2010;10:615\u2013623.", "ArticleIdList": ["20500151"]}, {"Citation": "Lee K-H, Huang E-S, Piantadosi C, Pagano JS, Geissman TA. Cytotoxicity of sesquiterpene lactones. Cancer Res. 1971;31:1649\u20131654.", "ArticleIdList": ["4330633"]}, {"Citation": "Zhang S, Won Y-K, Ong C-N, Shen H-M. Anti-cancer potential of sesquiterpene lactones: Bioactivity and molecular mechanisms. Curr. Med. Chem. - Anti-Cancer Agents. 2005;5:239\u2013249.", "ArticleIdList": ["15992352"]}, {"Citation": "Ghantous A, Gali-Muhtasib H, Vuorela H, Saliba NA, Darwiche N. What made sesquiterpene lactones reach cancer clinical trials? Drug Disc. Today. 2010;15:668\u2013678.", "ArticleIdList": ["20541036"]}, {"Citation": "Merfort I. Perspectives on sesquiterpene lactones in inflammation and cancer. Curr. Drug Targets. 2011;12:1560\u20131573.", "ArticleIdList": ["21561425"]}, {"Citation": "Orofino Kreuger MR, Grootjans S, Biavatti MW, Vandenabeele P, D'Herde K. Sesquiterpene lactones as drugs with multiple targets in cancer treatment: focus on parthenolide. Anti-cancer Drugs. 2012;23:883\u2013896.", "ArticleIdList": ["22797176"]}, {"Citation": "Suffness M, Douros J. Current status of the NCI plant and animal product program. J. Nat. Prod. 1982;45:1\u201314.", "ArticleIdList": ["7069421"]}, {"Citation": "Hall IH, Grippo AA, Holbrook DJ, Chang J-J, Yang L-M, Chaney SG, Lee K-H. Renal, hepatic, cardiac and thymic acute toxicity afforded by bis(helenalinyl)malonate in BDF1 mice. Toxicology. 1990;64:205\u2013216.", "ArticleIdList": ["2219141"]}, {"Citation": "Ramos A, Rivero R, Visozo A, Piloto J, Garcia A. Parthenin, a sesquiterpene lactone of Parthenium hysterophorus L. is a high toxicity clastogen. Mutat. Res. 2002;514:19\u201327.", "ArticleIdList": ["11815241"]}, {"Citation": "Salapovic H, Geier J, Reznicek G. Quantification of sesquiterpene lactones in Asteraceae plant extracts: Evaluation of their allergenic potential. Sci. Pharm. 2013;81:807\u2013818.", "ArticleIdList": ["PMC3791941", "24106675"]}, {"Citation": "Amorim MHR, Gil da Costa RM, Lopes C, Bastos MMSM. Sesquiterpene lactones: Adverse health effects and toxicity mechanisms. Crit. Rev. Toxicol. 2013;43:559\u2013579.", "ArticleIdList": ["23875764"]}, {"Citation": "Chaturvedi D, Goswami A, Pratim Saikia P, Barua NC, Rao PG. Artemisinin and its derivatives: a novel class of anti-malarial and anti-cancer agents. Chem. Soc. Rev. 2010;39:435\u2013454.", "ArticleIdList": ["20111769"]}, {"Citation": "Crespo-Ortiz MP, Wei MQ. Antitumor activity of artemisinin and its derivatives: From a well-known antimalarial agent to a potential anticancer drug. J. Biomed. Biotechnol. 2012:1\u201318.", "ArticleIdList": ["PMC3228295", "22174561"]}, {"Citation": "Lai HC, Singh NP, Sasaki T. Development of artemisinin compounds for cancer treatment. Invest. New Drugs. 2013;31:230\u2013246.", "ArticleIdList": ["22935909"]}, {"Citation": "Kinghorn AD, Carcache-Blanco EJ, Chai H-B, Orjala J, Farnsworth NR, Soejarto DD, Oberlies NH, Wani MC, Kroll DJ, Pearce CJ, Swanson SM, Kramer RA, Rose WC, Fairchild CR, Vite GD, Emanuel S, Jarjoura D, Cope FO. Discovery of anticancer agents of diverse natural origin. Pure Appl. Chem. 2009;81:1051\u20131063.", "ArticleIdList": ["PMC2765058", "20046887"]}, {"Citation": "Cragg GM, Grothaus PG, Newman DJ. New horizons for old drugs and drug leads. J. Nat. Prod. 2014;77:703\u2013723.", "ArticleIdList": ["24499205"]}, {"Citation": "Coordinating Group for Research on the Structure of Qing Hau Sau. A new type of sesquiterpene lactone \u2013 Qing Hau Sau. Kexue Tongbao. 1977;22:142."}, {"Citation": "Klayman DL, Lin AJ, Acton N, Scovill JP, Hoch JM, Milhous WK, Theoharides AD, Dobek AS. Isolation of artemisinin (qinghaosu) from Artemisia annua growing in the United States. J. Nat. Prod. 1984;47:715\u2013717.", "ArticleIdList": ["6387056"]}, {"Citation": "Lisgarten JN, Potter BS, Bantuzeko C, Palmer RA. Structure, absolute configuration, and conformation of the antimalarial compound, artemisinin. J. Chem. Crystallogr. 1998;28:539\u2013543."}, {"Citation": "Zhu C, Cook SP. A concise synthesis of (+)-artemisinin. J. Am. Chem. Soc. 2012;134:13577\u201313579.", "ArticleIdList": ["22866604"]}, {"Citation": "Janse CJ, Waters AP, Kos J, Lugt CB. Comparison of in vivo and in vitro antimalarial activity of artemisinin, dihydroartemisinin and sodium artesunate in the Plasmodium berghei-rodent model. Int. J. Parasitol. 1994;24:589\u2013594.", "ArticleIdList": ["8082988"]}, {"Citation": "Jung M, Lee K, Kim H, Park M. Recent advances in artemisinin and its derivatives as antimalarial and antitumor agents. Curr. Med. Chem. 2004;11:1265\u20131284.", "ArticleIdList": ["15134519"]}, {"Citation": "Brossi A, Venugopalan B, Dominguez Gerpe L, Yeh HJC, Flippen-Anderson JL, Buchs P, Luo XD, Milhous W, Peters W. Arteether, a new antimalarial drug: Synthesis and antimalarial properties. J. Med. Chem. 1988;31:645\u2013650.", "ArticleIdList": ["3279208"]}, {"Citation": "Szychowski J, Truchon J-F, Bennani YL. Natural products in medicine: Transformational outcome of synthetic chemistry. J. Med. Chem. 2014;57:9292\u20139308.", "ArticleIdList": ["25144261"]}, {"Citation": "Ho WE, Peh HY, Chan TK, Wong WSF. Artemisinins: Pharmacological actions beyond anti-malarial. Pharmacol. Ther. 2014;142:126\u2013139.", "ArticleIdList": ["24316259"]}, {"Citation": "Hou J, Wang D, Zhang R, Wang H. Experimental therapy of hepatoma with artemisinin and its derivatives: In vitro and in vivo activity, chemosensitization and mechanisms of action. Clin. Cancer. Res. 2008;14:5519\u20135530.", "ArticleIdList": ["18765544"]}, {"Citation": "Nakase I, Gallis B, Takatani-Nakase T, Oh S, Lacoste E, Singh NP, Goodlett DR, Tanaka S, Futaki S, Lai H, Sasaki T. Transferrin receptor-dependent cytotoxicity of artemisinin\u2013transferrin conjugates on prostate cancer cells and induction of apoptosis. Cancer Lett. 2009;274:290\u2013298.", "ArticleIdList": ["19006645"]}, {"Citation": "Zhang S, Gerhard GS. Heme mediates cytotoxicity from artemisinin and serves as a general anti-proliferation target. PLoS ONE. 2009;4:e7472.", "ArticleIdList": ["PMC2764339", "19862332"]}, {"Citation": "Soomro S, Langenberg T, Mahringer A, Konkimalla VB, Horwedel C, Holenya P, Brand A, Cetin C, Fricker G, Dewerchin M, Carmeliet P, Conway EM, Jansen H, Efferth T. Design of novel artemisinin-like derivatives with cytotoxic and anti-angiogenic properties. J. Cell. Mol. Med. 2011;15:1122\u20131135.", "ArticleIdList": ["PMC3822625", "20629994"]}, {"Citation": "Disbrow GL, Baege AC, Kierpiec KA, Yuan H, Centeno JA, Thibodeaux CA, Hartmann D, Schlegel R. Dihydroartemisinin is cytotoxic to papillomavirus-expressing epithelial cells in vitro and in vivo. Cancer Res. 2005;65:10854\u201310861.", "ArticleIdList": ["16322232"]}, {"Citation": "Lai H, Singh NP. Selective cancer cell cytotoxicity from exposure to dihydroartemisinin and holotransferrin. Cancer Lett. 1995;91:41\u201346.", "ArticleIdList": ["7750093"]}, {"Citation": "Singh NP, Lai H. Selective toxicity of dihydroartemisinin and holotransferrin toward human breast cancer cells. Life Sci. 2001;70:49\u201356.", "ArticleIdList": ["11764006"]}, {"Citation": "Moore JC, Lai H, Li J-R, Ren R-L, McDougall JA, Singh NP, Chou C-K. Oral administration of dihydroartemisinin and ferrous sulfate retarded implanted fibrosarcoma growth in the rat. Cancer Lett. 1995;98:83\u201387.", "ArticleIdList": ["8529210"]}, {"Citation": "Farsam V, Hassan ZM, Zavaran-Hosseini A, Noori S, Mahdavi M, Ranjbar M. Antitumor and immunomodulatory properties of artemether and its ability to reduce CD4+ CD25+ FoxP3+ T reg cells in vivo. Int. Immunopharmacol. 2011;11:1802\u20131808.", "ArticleIdList": ["21824530"]}, {"Citation": "Singh NP, Panwar VK. Case report of a pituitary macroadenoma treated with artemether Integr. Cancer Ther. 2006;5:391\u2013394.", "ArticleIdList": ["17101767"]}, {"Citation": "Hooft van Huijsduijnen R, Guy RK, Chibale K, Haynes RK, Peitz I, Kelter G, Phillips MA, Vennerstrom JL, Yuthavong Y, Wells TNC. Anticancer properties of distinct antimalarial drug classes. PLoS One. 2013;8:e82962.", "ArticleIdList": ["PMC3877007", "24391728"]}, {"Citation": "Liu L, Zuo LF, Guo JW. Reversal of multidrug resistance by the anti-malaria drug artesunate in the esophageal cancer Eca109/ABCG2 cell line. Oncology Lett. 2013;6:1475\u20131481.", "ArticleIdList": ["PMC3813605", "24179544"]}, {"Citation": "Michaelis M, Kleinschmidt MC, Barth S, Rothweiler F, Geiler J, Breitling R, Mayer B, Deubzer H, Witt O, Kreuter J, Doerr HW, Cinatl J, Cinatl J. Anti-cancer effects of artesunate in a panel of chemoresistant neuroblastoma cell lines. Biochem. Pharmacol. 2010;79:130\u2013136.", "ArticleIdList": ["19698702"]}, {"Citation": "Nguyen HT, Tran TH, Kim JO, Yong CS, Nguyen CN. Enhancing the in vitro anti-cancer efficacy of artesunate by loading into poly-D,L-lactide-co-glycolide (PLGA) nanoparticles. Arch. Pharm. Res. 2015;38:716\u2013724.", "ArticleIdList": ["24968925"]}, {"Citation": "Hamacher-Brady A, Stein HA, Turschner S, Toegel I, Mora R, Jennewein N, Efferth T, Eils R, Brady NR. Artesunate activates mitochondrial apoptosis in breast cancer cells via iron-catalyzed lysosomal reactive oxygen species production. J. Biol. Chem. 2011;286:6587\u20136601.", "ArticleIdList": ["PMC3057810", "21149439"]}, {"Citation": "Li PCH, Lam E, Roos WP, Zdzienicka MZ, Kaina B, Efferth T. Artesunate derived from traditional Chinese medicine induces DNA damage and repair. Cancer Res. 2008;68:4347\u20134351.", "ArticleIdList": ["18519695"]}, {"Citation": "Berdelle N, Nikolova T, Quiros S, Efferth T, Kaina B. Artesunate induces oxidative DNA damage, sustained DNA double-strand breaks, and the ATM/ATR damage response in cancer cells. Mol. Cancer Ther. 2011;10:2224\u20132233.", "ArticleIdList": ["21998290"]}, {"Citation": "Rutteman GR, Erich SA, Mol JA, Spee B, Grinwis GCM, Fleckenstein L, London CA, Efferth T. Safety and efficacy field study of artesunate for dogs with non-resectable tumours. Anticancer Res. 2013;33:1819\u20131827.", "ArticleIdList": ["23645726"]}, {"Citation": "Jansen FH, Aboubi I, Kouassi Comoe JC, De Cnodder T, Jansen N, Tschulakow A, Efferth T. First study of oral artenimol-R in advanced cervical cancer: clinical benefit, tolerability and tumor markers. Anticancer Res. 2011;31:4417\u20134422.", "ArticleIdList": ["22199309"]}, {"Citation": "Liu Y, Lok C-N, Ko BC-B, Shum TY-T, Wong M-K, Che C-M. Subcellular localization of a fluorescent artemisinin derivative to endoplasmic reticulum. Org. Lett. 2010;12:1420\u20131423.", "ArticleIdList": ["20192248"]}, {"Citation": "Woerdenbag HJ, Moskal TA, Pras N, Malingr\u00e9 TM, El-Feraly FS, Kampinga HH, Konings AWT. Cytotoxicity of artemisinin-related endoperoxides to Ehrlich ascites tumor cells. J. Nat. Prod. 1993;56:849\u2013856.", "ArticleIdList": ["8350087"]}, {"Citation": "Beekman AC, Barentsen ARW, Woerdenbag HJ, Van Uden W, Pras N, Konings AWT, El-Feraly FS, Galal AM, Wikstr\u00f6m HV. Stereochemistry-dependent cytotoxicity of some artemisinin derivatives. J. Nat. Prod. 1997;60:325\u2013330.", "ArticleIdList": ["9134741"]}, {"Citation": "Ren Y, Jim\u00e9nez F, Garc\u00eda R, Mej\u00eda M, Chai H, Farnsworth NR, Soejarto DD, Kinghorn AD. A cytotoxic dimeric furanoheliangolide from Piptocoma rufescens. Tetrahedron Lett. 2013;54:5457\u20135460.", "ArticleIdList": ["PMC3804354", "24159245"]}, {"Citation": "Posner GH, Ploypradith P, Hapangama W, Wang D, Cumming JN, Dolan P, Kensler TW, Klinedinst D, Shapiro TA, Zheng QY, Murray CK, Pilkington LG, Jayasinghe LR, Bray JF, Daughenbaugh R. Trioxane dimers have potent antimalarial, antiproliferative and antitumor activities in vitro. Bioorg. Med. Chem. 1997;5:1257\u20131265.", "ArticleIdList": ["9377085"]}, {"Citation": "Posner GH, McRiner AJ, Paik I-H, Sur S, Borstnik K, Xie S, Shapiro TA, Alagbala A, Foster B. Anticancer and antimalarial efficacy and safety of artemisinin-derived trioxane dimers in rodents. J. Med. Chem. 2004;47:1299\u20131301.", "ArticleIdList": ["14971910"]}, {"Citation": "Alagbala AA, McRiner AJ, Borstnik K, Labonte T, Chang W, D'Angelo JG, Posner GH, Foster BA. Biological mechanisms of action of novel C-10 non-acetal trioxane dimers in prostate cancer cell lines. J. Med. Chem. 2006;49:7836\u20137842.", "ArticleIdList": ["PMC5545891", "17181166"]}, {"Citation": "Rosenthal AS, Chen X, Liu JO, West DC, Hergenrother PJ, Shapiro TA, Posner GH. Malaria-infected mice are cured by a single oral dose of new dimeric trioxane sulfones which are also selectively and powerfully cytotoxic to cancer cells. J. Med. Chem. 2009;52:1198\u20131203.", "ArticleIdList": ["PMC2698029", "19186946"]}, {"Citation": "He R, Mott BT, Rosenthal AS, Genna DT, Posner GH, Arav-Boger R. An artemisinin-derived dimer has highly potent anti-cytomegalovirus (CMV) and anti-cancer activities. PLoS ONE. 2011;6:e24334.", "ArticleIdList": ["PMC3164168", "21904628"]}, {"Citation": "Singh NP, Lai HC, Park JS, Gerhardt TE, Kim BJ, Wang S, Sasaki T. Effects of artemisinin dimers on rat breast cancer cells in vitro and in vivo. Anticancer Res. 2011;31:4111\u20134114.", "ArticleIdList": ["22199268"]}, {"Citation": "Mott BT, He R, Chen X, Fox JM, Civin CI, Arav-Boger R, Posner GH. Artemisinin-derived dimer phosphate esters as potent anti-cytomegalovirus (anti-CMV) and anti-cancer agents: A structure-activity study. Bioorg. Med. Chem. 2013;21:3702\u20133707.", "ArticleIdList": ["PMC3685872", "23673218"]}, {"Citation": "Galal AM, Gul W, Slade D, Ross SA, Feng S, Hollingshead MG, Alley MC, Kaur G, ElSohly MA. Synthesis and evaluation of dihydroartemisinin and dihydroartemisitene acetal dimers showing anticancer and antiprotozoal activity. Bioorg. Med. Chem. 2009;17:741\u2013751.", "ArticleIdList": ["19084416"]}, {"Citation": "Xie L, Zhao Y, Zhai X, Li P, Liu C, Li Y, Gong P. The application of tandem aza-Wittig reaction to synthesize artemisinin-guanidine hybrids and their anti-tumor activity. Arch. Pharm. Chem. Life Sci. 2011;344:631\u2013638.", "ArticleIdList": ["21984013"]}, {"Citation": "Reiter C, Herrmann A, Capci A, Efferth T, Tsogoeva SB. New artesunic acid homodimers: Potent reversal agents of multidrug resistance in leukemia cells. Bioorg. Med. Chem. 2012;20:5637\u20135641.", "ArticleIdList": ["22884578"]}, {"Citation": "Herout V, Sou\u010dek M, \u0160orm F. Parthenolide, another sesquiterpenic lactone with a ten-membered ring. Chem. Ind. 1959:1069\u20131070."}, {"Citation": "Sou\u010dek M, Herout V, \u0160orm F. On terpenes. CXVIII. Constitution of parthenolide. Coll. Czech. Chem. Commun. 1961;26:803\u2013810."}, {"Citation": "Govindachari TR, Joshi BS, Kamat VN. Structure of parthenolide. Tetrahedron. 1965;21:1509\u20131519."}, {"Citation": "Bawdekar AS, Kelkar GR, Bhattacharyya SC. Terpenoids. LXXXIX. Absolute configuration of parthenolide. Tetrahedron Lett. 1966:1225\u20131227."}, {"Citation": "Quick A, Rogers D. Crystal and molecular structure of parthenolide [4,5-epoxygermacra-1 (10), 11(13)-dien-12,6-olactone] J. Chem. Soc., Perkin Trans. II. 1976:465\u2013469."}, {"Citation": "Long J, Zhang S-F, Wang P-P, Zhang X-M, Yang Z-J, Zhang Q, Chen Y. Total syntheses of parthenolide and its analogues with macrocyclic stereocontrol. J. Med. Chem. 2014;57:7098\u20137112.", "ArticleIdList": ["25102048"]}, {"Citation": "Ghantous A, Sinjab A, Herceg Z, Darwiche N. Parthenolide: from plant shoots to cancer roots. Drug Discov. Today. 2013;18:894\u2013905.", "ArticleIdList": ["23688583"]}, {"Citation": "Zunino SJ, Ducore JM, Storms DH. Parthenolide induces significant apoptosis and production of reactive oxygen species in high-risk pre-B leukemia cells. Cancer Lett. 2007;254:119\u2013127.", "ArticleIdList": ["17470383"]}, {"Citation": "Fonrose X, Ausseil F, Soleilhac E, Masson V, David B, Pouny I, Cintrat J-C, Rousseau B, Barette C, Massiot G, Lafanech\u00e8re L. Parthenolide inhibits tubulin carboxypeptidase activity. Cancer Res. 2007;67:3371\u20133378.", "ArticleIdList": ["17409447"]}, {"Citation": "Kishida Y, Yoshikawa H, Myoui A. Parthenolide, a natural inhibitor of NF-\u03baB, inhibits lung colonization of murine osteosarcoma cells. Clin. Cancer Res. 2007;13:59\u201367.", "ArticleIdList": ["17200339"]}, {"Citation": "Liu Z, Liu S, Xie Z, Pavlovicz RE, Wu J, Chen P, Aimiuwu J, Pang J, Bhasin D, Neviani P, Fuchs JR, Plass C, Li P-K, Li C, Huang TH-M, Wu L-C, Rush L, Wang H, Perrotti D, Marcucci G, Chan KK. Modulation of DNA methylation by a sesquiterpene lactone parthenolide. J. Pharmacol. Exp. Ther. 2009;329:505\u2013514.", "ArticleIdList": ["PMC2672871", "19201992"]}, {"Citation": "Oka D, Nishimura K, Shiba M, Nakai Y, Arai Y, Nakayama M, Takayama H, Inoue H, Okuyama A, Nonomura N. Sesquiterpene lactone parthenolide suppresses tumor growth in a xenograft model of renal cell carcinoma by inhibiting the activation of NF-\u03baB. Int. J. Cancer. 2007;120:2576\u20132581.", "ArticleIdList": ["17290398"]}, {"Citation": "Yun B-R, Lee M-J, Kim J-H, Kim I-H, Yu G-R, Kim D-G. Enhancement of parthenolide-induced apoptosis by a PKC-alpha inhibition through heme oxygenase-1 blockage in cholangiocarcinoma cells. Exp. Mol. Med. 2010;42:787\u2013797.", "ArticleIdList": ["PMC2992858", "20938215"]}, {"Citation": "Zhang D, Qiu L, Jin X, Guo Z, Guo C. Nuclear factor-\u03baB inhibition by parthenolide potentiates the efficacy of taxol in non-small cell lung cancer in vitro and in vivo. Mol. Cancer Res. 2009;7:1139\u20131149.", "ArticleIdList": ["19584264"]}, {"Citation": "Sweeney CJ, Mehrotra S, Sadaria MR, Kumar S, Shortle NH, Roman Y, Sheridan C, Campbell RA, Murry DJ, Badve S, Nakshatri H. The sesquiterpene lactone parthenolide in combination with docetaxel reduces metastasis and improves survival in a xenograft model of breast cancer. Mol. Cancer Ther. 2005;4:1004\u20131012.", "ArticleIdList": ["15956258"]}, {"Citation": "Mathema VB, Koh Y-S, Thakuri BC, Sillanp\u00e4\u00e4 M. Parthenolide, a sesquiterpene lactone, expresses multiple anti-cancer and anti-inflammatory activities. Inflammation. 2012;35:560\u2013565.", "ArticleIdList": ["21603970"]}, {"Citation": "Curry EA, III, Murry DJ, Yoder C, Fife K, Armstrong V, Nakshatri H, O'Connell M, Sweeney CJ. Phase I dose escalation trial of feverfew with standardized doses of parthenolide in patients with cancer. Invest. New Drugs. 2004;22:299\u2013305.", "ArticleIdList": ["15122077"]}, {"Citation": "Neelakantan S, Nasim S, Guzman ML, Jordan CT, Crooks PA. Aminoparthenolides as novel anti-leukemic agents: discovery of the NF-\u03baB inhibitor, DMAPT (LC-1) Bioorg. Med. Chem. Lett. 2009;19:4346\u20134349.", "ArticleIdList": ["19505822"]}, {"Citation": "Shanmugam R, Kusumanchi P, Cheng L, Crooks P, Neelakantan S, Matthews W, Nakshatri H, Sweeney CJ. A water-soluble parthenolide analogue suppresses in vivo prostate cancer growth by targeting NF\u03baB and generating reactive oxygen species. Prostate. 2010;70:1074\u20131086.", "ArticleIdList": ["20209491"]}, {"Citation": "Estabrook NC, Chin-Sinex H, Borgmann AJ, Dhaemers RM, Shapiro RH, Gilley D, Huda N, Crooks P, Sweeney C, Mendonca MS. Inhibition of NF-\u03baB and DNA double-strand break repair by DMAPT sensitizes non-small-cell lung cancers to X-rays. Free. Rad. Biol. Med. 2011;51:2249\u20132258.", "ArticleIdList": ["22019440"]}, {"Citation": "Shanmugam R, Kusumanchi P, Appaiah H, Cheng L, Crooks P, Neelakantan S, Peat T, Klaunig J, Matthews W, Nakshatri H, Sweeney CJ. A water soluble parthenolide analog suppresses in vivo tumor growth of two tobacco-associated cancers, lung and bladder cancer, by targeting NF-\u03baB and generating reactive oxygen species. Int. J. Cancer. 2011;128:2481\u20132494.", "ArticleIdList": ["PMC2982935", "20669221"]}, {"Citation": "Yip-Schneider MT, Wu H, Hruban RH, Lowy AM, Crooks PA, Schmidt CM. Efficacy of dimethylaminoparthenolide and sulindac in combination with gemcitabine in a genetically engineered mouse model of pancreatic cancer. Pancreas. 2013;42:160\u2013167.", "ArticleIdList": ["22699205"]}, {"Citation": "Holcomb BK, Yip-Schneider MT, Waters JA, Beane JD, Crooks PA, Schmidt CM. Dimethylamino parthenolide enhances the inhibitory effects of gemcitabine in human pancreatic cancer cells. J. Gastrointest Surg. 2012;16:1333\u20131340.", "ArticleIdList": ["22618517"]}, {"Citation": "Guzman ML, Rossi RM, Neelakantan S, Li X, Corbett CA, Hassane DC, Becker MW, Bennett JM, Sullivan E, Lachowicz JL, Vaughan A, Sweeney CJ, Matthews W, Carroll M, Liesveld JL, Crooks PA, Jordan CT. An orally bioavailable parthenolide analog selectively eradicates acute myelogenous leukemia stem and progenitor cells. Blood. 2007;110:4427\u20134435.", "ArticleIdList": ["PMC2234793", "17804695"]}, {"Citation": "Choi J-H, Lee K-T. Costunolide-induced apoptosis in human leukemia cells: Involvement of c-Jun N-terminal kinase activation. Biol. Pharm. Bull. 2009;32:1803\u20131808.", "ArticleIdList": ["19801848"]}, {"Citation": "Park HW, Lee JH, Choi S-U, Baek N-I, Kim S-H, Yang JH, Kim DK. Cytotoxic germacranolide sesquiterpenes from the bark of Magnolia kobus. Arch. Pharm. Res. 2010;33:71\u201374.", "ArticleIdList": ["20191346"]}, {"Citation": "Hsu J-L, Pan S-L, Ho Y-F, Hwang T-L, Kung F-L, Guh J-H. Costunolide induces apoptosis through nuclear calcium2+ overload and DNA damage response in human prostate cancer. J. Urol. 2011;185:1967\u20131974.", "ArticleIdList": ["21421237"]}, {"Citation": "Yang Y-I, Kim J-H, Lee K-T, Choi J-H. Costunolide induces apoptosis in platinum-resistant human ovarian cancer cells by generating reactive oxygen species. Gynecol. Oncol. 2011;123:588\u2013596.", "ArticleIdList": ["21945308"]}, {"Citation": "Rasul A, Yu B, Yang L-F, Arshad M, Khan M, Ma T, Yang H. Costunolide, a sesquiterpene lactone induces G2/M phase arrest and mitochondria-mediated apoptosis in human gastric adenocarcinoma SGC-7901 cells. J. Med. Plants Res. 2012;6:1191\u20131200."}, {"Citation": "Choi YK, Seo HS, Choi HS, Choi HS, Kim SR, Shin YC, Ko S-G. Induction of Fas-mediated extrinsic apoptosis, p21WAF1-related G2/M cell cycle arrest and ROS generation by costunolide in estrogen receptor-negative breast cancer cells, MDA-MB-231. Mol. Cell. Biochem. 2012;363:119\u2013128.", "ArticleIdList": ["22147197"]}, {"Citation": "Kurokawa T, Nakanishi K, Wu W, Hsu HY, Maruyama M, Kupchan SM. Deoxyelephantopin and its interrelation with elephantopin. Tetrahedron Lett. 1970:2863\u20132866."}, {"Citation": "Zhang D, Haruna M, McPhail AT, Lee K-H. Cytotoxic germacranolides of Elephantopus carolinianus and the structure and stereochemistry of isodeoxyelephantopin. Phytochemistry. 1986;25:899\u2013904."}, {"Citation": "But PP-H, Hon P-M, Cao H, Chan TWD, Wu B-M, Mak TCW, Che C-T. Sesquiterpene lactones from Elephantopus scaber. Phytochemistry. 1997;44:113\u2013116."}, {"Citation": "Ichikawa H, Nair MS, Takada Y, Sheeja DBA, Kumar MAS, Oommen OV, Aggarwal BB. Isodeoxyelephantopin, a novel sesquiterpene lactone, potentiates apoptosis, inhibits invasion, and abolishes osteoclastogenesis through suppression of nuclear factor-\u03baB (NF-\u03baB) activation and NF-\u03baB-regulated gene expression. Clin. Cancer Res. 2006;12:5910\u20135918.", "ArticleIdList": ["17021000"]}, {"Citation": "Zou G, Gao Z, Wang J, Zhang Y, Ding H, Huang J, Chen L, Guo Y, Jiang H, Shen X. Deoxyelephantopin inhibits cancer cell proliferation and functions as a selective partial agonist against PPAR\u03b3. Biochem. Pharmacol. 2008;75:1381\u20131392.", "ArticleIdList": ["18164690"]}, {"Citation": "Huang C-C, Lo C-P, Chiu C-Y, Shyur L-F. Deoxyelephantopin, a novel multifunctional agent, suppresses mammary tumour growth and lung metastasis and doubles survival time in mice. Br. J. Pharmacol. 2010;159:856\u2013871.", "ArticleIdList": ["PMC2829211", "20105176"]}, {"Citation": "Lee W-L, Wen T-N, Shiau J-Y, Shyur L-F. Differential proteomic profiling identifies novel molecular targets of paclitaxel and phytoagent deoxyelephantopin against mammary adenocarcinoma cells. J. Proteome Res. 2010;9:237\u2013253.", "ArticleIdList": ["19894775"]}, {"Citation": "Su M, Chung HY, Li Y. Deoxyelephantopin from Elephantopus scaber L. induces cell-cycle arrest and apoptosis in the human nasopharyngeal cancer CNE cells. Biochem. Biophys. Res. Commun. 2011;411:342\u2013347.", "ArticleIdList": ["21741953"]}, {"Citation": "Xu G, Liang Q, Gong Z, Yu W, He S, Xi L. Antitumor activities of the four sesquiterpene lactones from Elephantopus scaber L. Exp. Oncol. 2006;28:106\u2013109.", "ArticleIdList": ["16837899"]}, {"Citation": "Ren Y, Mu\u00f1oz Acu\u00f1a U, Jim\u00e9nez F, Garc\u00eda R, Mej\u00eda M, Chai H, Gallucci JC, Farnsworth NR, Soejarto DD, Carcache de Blanco EJ, Kinghorn AD. Cytotoxic and NF-\u03baB inhibitory sesquiterpene lactones from Piptocoma rufescens. Tetrahedron. 2012;68:2671\u20132678.", "ArticleIdList": ["PMC3369275", "22685350"]}, {"Citation": "Spear SA, Burns SS, Oblinger JL, Ren Y, Pan L, Kinghorn AD, Welling DB, Chang L-S. Natural compounds as potential treatments of NF2-deficient schwannoma and meningioma: cucurbitacin D and goyazensolide. Otol. Neurotol. 2013;34:1519\u20131527.", "ArticleIdList": ["PMC4334125", "23928514"]}, {"Citation": "Mu\u00f1oz Acu\u00f1a U, Shen Q, Ren Y, Lantvit DD, Wittwer JA, Kinghorn AD, Swanson SM, Carcache de Blanco EJ. Goyazensolide induces apoptosis in cancer cells in vitro and in vivo. Int. J. Cancer Res. 2013;9:36\u201353.", "ArticleIdList": ["PMC4303185", "25621077"]}, {"Citation": "Vichnewski W, Sarti SJ, Gilbert B, Herz W. Goyazensolide, a schistosomicidal heliangolide from Eremanthus goyazensis. Phytochemistry. 1976;15:191\u2013193."}, {"Citation": "Herz W, Goedken VL. Structure of goyazensolide and its congeners. J. Org. Chem. 1982;47:2798\u20132800."}, {"Citation": "Kupchan SM, Eakin MA, Thomas AM. Tumor inhibitors. 69. Structure-cytotoxicity relations among the sesquiterpene lactones. J. Med. Chem. 1971;14:1147\u20131152.", "ArticleIdList": ["5116225"]}, {"Citation": "Scotti MT, Fernandes MB, Ferreira MJP, Emerenciano VP. Quantitative structure-activity relationship of sesquiterpene lactones with cytotoxic activity. Bioorg. Med. Chem. 2007;15:2927\u20132934.", "ArticleIdList": ["17336532"]}, {"Citation": "Wagner S, Hofmann A, Siedle B, Terfloth L, Merfort I, Gasteiger J. Development of a structural model for NF-\u03baB inhibition of sesquiterpene lactones using self-organizing neural networks. J. Med. Chem. 2006;49:2241\u20132252.", "ArticleIdList": ["16570920"]}, {"Citation": "Doan NTQ, Paulsen ES, Sehgal P, M\u00f8ller JV, Nissen P, Denmeade SR, Isaacs JT, Dionne CA, Christensen SB. Targeting thapsigargin towards tumors. Steroids. 2015;97:2\u20137.", "ArticleIdList": ["PMC4696022", "25065587"]}, {"Citation": "Makunga NP, J\u00e4ger AK, van Staden J. Micropropagation of Thapsia garganica\u2013a medicinal plant. Plant Cell Rep. 2003;21:967\u2013973.", "ArticleIdList": ["12835906"]}, {"Citation": "Christensen SB, Rasmussen U, Christophersen C. Thapsigargin, constitution of a sesquiterpene lactone histamine liberator from Thapsia garganica. Tetrahedron Lett. 1980;21:3829\u20133830."}, {"Citation": "Christensen SB, Larsen IK, Rasmussen U, Christophersen C. Thapsigargin and thapsigargicin, two histamine liberating sesquiterpene lactones from Thapsia garganica. X-ray analysis of the 7,11-epoxide of thapsigargin. J. Org. Chem. 1982;47:649\u2013652."}, {"Citation": "Christensen SB, Norup E. Absolute configurations of the histamine liberating sesquiterpene lactones thapsigargin and trilobolide. Tetrahedron Lett. 1985;26:107\u2013110."}, {"Citation": "Ley SV, Antonello A, Balskus EP, Booth DT, Christensen SB, Cleator E, Gold H, H\u00f6egenauer K, H\u00fcenger U, Myers RM, Oliver SF, Simic O, Smith MD, S\u00f8hoel H, Woolford AJA. Synthesis of the thapsigargins. Proc. Natl. Acad. Sci. 2004;101:12073\u201312078.", "ArticleIdList": ["PMC514437", "15226504"]}, {"Citation": "Ball M, Andrews SP, Wierschem F, Cleator E, Smith MD, Ley SV. Total Synthesis of thapsigargin, a potent SERCA pump inhibitor. Org. Lett. 2007;9:663\u2013666.", "ArticleIdList": ["17256950"]}, {"Citation": "Inesi G, Sagara Y. Thapsigargin, a high affinity and global inhibitor of intracellular Ca2+ transport ATPases. Arch. Biochem. Biophys. 1992;298:313\u2013317.", "ArticleIdList": ["1416963"]}, {"Citation": "Liu H, Jensen KG, Tran LM, Chen M, Zhai L, Olsen CE, S\u00f8hoel H, Denmeade SR, Isaacs JT, Christensen SB. Cytotoxic phenylpropanoids and an additional thapsigargin analogue isolated from Thapsia garganica. Phytochemistry. 2006;67:2651\u20132658.", "ArticleIdList": ["17098264"]}, {"Citation": "Jin T, Nakatani H, Taguchi T, Sonobe H, Morimoto N, Sugimoto T, Akimori T, Nakano T, Namikawa T, Okabayashi T, Kobayashi M, Araki K. Thapsigargin enhances cell death in the gastrointestinal stromal tumor cell line, GIST-T1, by treatment with imatinib (Glivec) J. Health Sci. 2006;52:110\u2013117."}, {"Citation": "Min K-J, Kim HS, Park EJ, Kwon TK. Melatonin enhances thapsigargin-induced apoptosis through reactive oxygen species-mediated upregulation of CCAAT-enhancer-binding protein homologous protein in human renal cancer cells. J. Pineal Res. 2012;53:99\u2013106.", "ArticleIdList": ["22289049"]}, {"Citation": "Yamaguchi H, Bhalla K, Wang H-G. Bax plays a pivotal role in thapsigargin-induced apoptosis of human colon cancer HCT116 cells by controlling Smac/Diablo and Omi/HtrA2 release from mitochondria. Cancer Res. 2003;63:1483\u20131489.", "ArticleIdList": ["12670894"]}, {"Citation": "Huang L, Xu J, Li K, Zheng MH, Kumta S-M. Thapsigargin potentiates TRAIL-induced apoptosis in giant cell tumor of bone. Bone. 2004;34:971\u2013981.", "ArticleIdList": ["15193543"]}, {"Citation": "Wagner-Souza K, Echevarria-Lima J, Rodrigues LAP, Reis M, Rumjanek VM. Resistance to thapsigargin-induced intracellular calcium mobilization in a multidrug resistant tumour cell line. Mol. Cell. Biochem. 2003;252:109\u2013116.", "ArticleIdList": ["14577583"]}, {"Citation": "Christensen SB, Andersen A, Kromann H, Treiman M, Tombal B, Denmeade S, Isaacs JT. Thapsigargin analogs for targeting programmed death of androgen-independent prostate cancer cells. Bioorg. Med. Chem. 1999;7:1273\u20131280.", "ArticleIdList": ["10465403"]}, {"Citation": "S\u00f8hoel H, Lund Jensen A-M, M\u00f8ller JV, Nissen P, Denmeade SR, Isaacs JT, Olsen CE, Christensen SB. Natural products as starting materials for development of second-generation SERCA inhibitors targeted towards prostate cancer cells. Bioorg. Med. Chem. 2006;14:2810\u20132815.", "ArticleIdList": ["16412648"]}, {"Citation": "Jakobsen CM, Denmeade SR, Isaacs JT, Gady A, Olsen CE, Christensen SB. Design, synthesis, and pharmacological evaluation of thapsigargin analogues for targeting apoptosis to prostatic cancer cells. J. Med. Chem. 2001;44:4696\u20134703.", "ArticleIdList": ["11741487"]}, {"Citation": "Denmeade SR, Jakobsen CM, Janssen S, Khan SR, Garrett ES, Lilja H, Christensen SB, Isaacs JT. Prostate-specific antigen-activated thapsigargin prodrug as targeted therapy for prostate cancer. J. Natl. Cancer Inst. 2003;95:990\u20131000.", "ArticleIdList": ["12837835"]}, {"Citation": "Vander Griend DJ, Antony L, Dalrymple SL, Xu Y, Christensen SB, Denmeade SR, Isaacs JT. Amino acid containing thapsigargin analogues deplete androgen receptor protein via synthesis inhibition and induce the death of prostate cancer cells. Mol. Cancer Ther. 2009;8:1340\u20131349.", "ArticleIdList": ["PMC3383025", "19417145"]}, {"Citation": "Simonsen HT, Drew DP, Lunde C. Perspectives on using Physcomitrella patens as an alternative production platform for thapsigargin and other terpenoid drug candidates. Perspect. Med. Chem. 2009;3:1\u20136.", "ArticleIdList": ["PMC2754923", "19812738"]}, {"Citation": "Zahara K, Tabassum S, Sabir S, Arshad M, Qureshi R, Amjad MS, Chaudhari SK. A review of therapeutic potential of Saussurea lappa\u2013An endangered plant from Himalaya. Asian Pac. J. Trop. Med. 2014;7S1:S60\u2013S69.", "ArticleIdList": ["25312191"]}, {"Citation": "Hsu Y-L, Wu L-Y, Kuo P-L. Dehydrocostuslactone, a medicinal plant-derived sesquiterpene lactone, induces apoptosis coupled to endoplasmic reticulum stress in liver cancer cells. J. Pharmacol. Exp. Ther. 2009;329:808\u2013819.", "ArticleIdList": ["19188481"]}, {"Citation": "Kim EJ, Lim SS, Park SY, Shin H-K, Kim J-S, Park JHY. Apoptosis of DU145 human prostate cancer cells induced by dehydrocostus lactone isolated from the root of Saussurea lappa. Food Chem. Toxicol. 2008;46:3651\u20133658.", "ArticleIdList": ["18848968"]}, {"Citation": "Fronczek FR, Vargas D, Parodi FJ, Fischer NH. Structure of the guaianolide dehydrocostus lactone. Acta Crystallogr. C. 1989;45:1829\u20131831."}, {"Citation": "Rigby JH, Wilson JZ. Total synthesis of guaianolides: (\u00b1)-dehydrocostus lactone and (\u00b1)-estafiatin. J. Am. Chem. Soc. 1984;106:8217\u20138224."}, {"Citation": "Choi EM. Dehydrocostus lactone prevents mitochondrial dysfunction in osteoblastic MC3T3-E1 cells. Eur. J. Pharmacol. 2011;664:1\u20137.", "ArticleIdList": ["21596031"]}, {"Citation": "Oh GS, Pae HO, Chung HT, Kwon JW, Lee JH, Kwon TO, Kwon SY, Chon BH, Yun YG. Dehydrocostus lactone enhances tumor necrosis factor-\u03b1-induced apoptosis of human leukemia HL-60 cells. Immunopharmacol. Immunotoxicol. 2004;26:163\u2013175.", "ArticleIdList": ["15209353"]}, {"Citation": "Kuo P-L, Ni W-C, Tsai E-M, Hsu Y-L. Dehydrocostuslactone disrupts signal transducers and activators of transcription 3 through up-regulation of suppressor of cytokine signaling in breast cancer cells. Mol. Cancer Ther. 2009;8:1328\u20131339.", "ArticleIdList": ["19383849"]}, {"Citation": "Wang C-Y, Tsai A-C, Peng C-Y, Chang Y-L, Lee K-H, Teng C-M, Pan S-L. Dehydrocostuslactone suppresses angiogenesis in vitro and in vivo through inhibition of Akt/GSK-3\u03b2 and mTOR signaling pathways. PLoS One. 2012;7:e31195.", "ArticleIdList": ["PMC3281050", "22359572"]}, {"Citation": "Herz W, Watanabe H, Miyazaki M, Kishida Y. Structures of parthenin and ambrosin. J. Am. Chem. Soc. 1962;84:2601\u20132610."}, {"Citation": "Gupta VK, Goswami KN, Bhutani KK. X-ray crystal structure analysis of parthenin\u2013a sesquiterpene lactone. Cryst. Res. Technol. 1994;29:373\u2013378."}, {"Citation": "Heathcock CH, Tice CM, Germroth TC. Synthesis of sesquiterpene antitumor lactones. 10. Total synthesis of (\u00b1)-parthenin. J. Am. Chem. Soc. 1982;104:6081\u20136091."}, {"Citation": "Shimoma F, Kusaka H, Azami H, Wada K, Suzuki T, Hagiwara H, Ando M. Total syntheses of (\u00b1)-hymenolin and (\u00b1)-parthenin. J. Org. Chem. 1998;63:3758\u20133763."}, {"Citation": "Reddy DM, Qazi NA, Sawant SD, Bandey AH, Srinivas J, Shankar M, Singh SK, Verma M, Chashoo G, Saxena A, Mondhe D, Saxena AK, Sethi VK, Taneja SC, Qazi GN, Kumar HMS. Design and synthesis of spiro derivatives of parthenin as novel anti-cancer agents. Eur. J. Med. Chem. 2011;46:3210\u20133217.", "ArticleIdList": ["21620534"]}, {"Citation": "Shah BA, Taneja SC, Sethi VK, Gupta P, Andotra SS, Chimni SS, Qazi GN. The formation of novel 1,3-dioxolanes: atypical Baylis-Hillman reaction of a sesquiterpene lactone parthenin. Tetrahedron Lett. 2007;48:955\u2013960."}, {"Citation": "Shah BA, Kaur R, Gupta P, Kumar A, Sethi VK, Andotra SS, Singh J, Saxena AK, Taneja SC. Structure-activity relationship (SAR) of parthenin analogues with pro-apoptotic activity: Development of novel anti-cancer leads. Bioorg. Med. Chem. Lett. 2009;19:4394\u20134398.", "ArticleIdList": ["19501509"]}, {"Citation": "Kumar A, Malik F, Bhushan S, Shah BA, Taneja SC, Pal HC, Wani ZA, Mondhe DM, Kaur J, Singh J. A novel parthenin analog exhibits anti-cancer activity: Activation of apoptotic signaling events through robust NO formation in human leukemia HL-60 cells. Chem. Biol. Interact. 2011;193:204\u2013215.", "ArticleIdList": ["21741372"]}, {"Citation": "Emerson MT, Caughlan CN, Herz W. The crystal and molecular structure of bromohelenalin. Tetrahedron Lett. 1964;12:621\u2013625."}, {"Citation": "Chapman DE, Holbrook DJ, Chaney SG, Hall IH, Lee K-H. In vivo and in vitro effects of helenalin on mouse hepatic microsomal cytochrome P450. Biochem. Pharmacol. 1991;41:229\u2013235.", "ArticleIdList": ["1989634"]}, {"Citation": "Kim SH, Oh SM, Kim TS. Induction of human leukemia HL-60 cell differentiation via a PKC/ERK pathway by helenalin, a pseudoguaianolide sesquiterpene lactone. Eur. J. Phamacol. 2005;511:89\u201397.", "ArticleIdList": ["15792776"]}, {"Citation": "Hoffmann R, von Schwarzenberg K, L\u00f3pez-An\u00f3n N, Rudy A, Wanner G, Dirsch VM, Vollmar AM. Helenalin bypasses Bcl-2-mediated cell death resistance by inhibiting NF-\u03baB and promoting reactive oxygen species generation. Biochem. Pharmacol. 2011;82:453\u2013463.", "ArticleIdList": ["21669190"]}, {"Citation": "Lee K-H, Ibuka T, Sims D, Muraoka O, Kiyokawa H, Hall IH, Kim HL. Antitumor agents. 44. Bis(helenalinyl) esters and related derivatives as novel potent antileukemic agents. J. Med. Chem. 1981;24:924\u2013927.", "ArticleIdList": ["7328595"]}, {"Citation": "Chen C-H, Yang L-M, Lee TT-Y, Shen Y-C, Zhang D-C, Pan D-J, McPhail AT, McPhail DR, Liu S-Y, Li D-H, Cheng Y-C, Lee K-H. Antitumor agents\u2013CLI. Bis(helenalinyl)glutarate and bis(isoalantodiol-B)glutarate, potent inhibitors of human DNA topoisomerase II. Bioorg. Med. Chem. 1994;2:137\u2013145.", "ArticleIdList": ["7922123"]}, {"Citation": "Nakanishi C, Toi M. Nuclear factor-\u03baB inhibitors as sensitizers to anticancer drugs. Nat. Rev. Cancer. 2005;5:297\u2013309.", "ArticleIdList": ["15803156"]}], "ReferenceList": []}], "History": [{"Year": "2014", "Month": "12", "Day": "1"}, {"Year": "2016", "Month": "4", "Day": "26"}, {"Year": "2016", "Month": "5", "Day": "9"}, {"Year": "2016", "Month": "5", "Day": "11", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "5", "Day": "11", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "2", "Day": "7", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "1", "Day": "1"}], "PublicationStatus": "ppublish", "ArticleIdList": ["27160533", "NIHMS813259", "PMC5012922", "10.2174/0929867323666160510123255", "CMC-EPUB-75563"]}}], "PubmedBookArticle": []}